1. Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests
- Author
-
Fausto Bogazzi, Giulia Marconcini, Agostino Maria Di Certo, Massimo Tonacchera, Daniele Cappellani, Fulvio Basolo, Liborio Torregrossa, Alessandro Mattiello, E. Ferrarini, Luca Manetti, Giada Cosentino, Luigi Bartalena, Patrizia Agretti, Claudio Urbani, and Giuseppina De Marco
- Subjects
Adult ,Male ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Thyrotropin receptor Antibody ,Amiodarone ,Trab ,CHO Cells ,medicine.disease_cause ,Amiodarone-induced thyrotoxicosis ,Autoimmunity ,Diagnosis, Differential ,Endocrinology ,Cricetulus ,Internal medicine ,Medicine ,Animals ,Humans ,Receptor ,Aged ,Autoantibodies ,Retrospective Studies ,biology ,business.industry ,autoimmunity ,AIT ,amiodarone ,thyrotoxicosis ,TRAb ,Receptors, Thyrotropin ,Middle Aged ,Phenotype ,Graves Disease ,Thyrotoxicosis ,Immunoglobulin G ,biology.protein ,Female ,Antibody ,business ,hormones, hormone substitutes, and hormone antagonists ,Biomarkers ,medicine.drug - Abstract
Introduction: Serum thyrotropin (TSH) receptor antibodies (TRAbs) are occasionally found in patients with amiodarone-induced thyrotoxicosis (AIT), and usually point to a diagnosis of type 1 AIT (AI...
- Published
- 2021